Anticholinergic activity and cognitive decline in Parkinson's disease.
Sergio E
SE
Starkstein
D018680:Cholinergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000188:drug therapy* / Q000453:epidemiology*; D015995:Prevalence; D012720:Severity of Illness Index
D018680:Cholinergic Antagonists